ArticleTranslational cancer research2025
Deep learning for fine-grained molecular-based colorectal cancer classification.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Colorectal cancer (CRC) is one of the most common malignancies globally and a major cause of cancer-related deaths. In the molecular diagnosis of CRC, microsatellite instability (MSI) status and mutations in genes such as Methods: In this study, we first collected H&E-stained tissue section images of 383 CRC patients from The First Hospital of Lanzhou University (LZUFH) and constructed the LZUFH_CRC dataset. Then, we proposed a hybrid DL model combining Convolutional Neural Network (CNN) and Vision Transformer (ViT) for fine-grained classification tasks in CRC. The model consists of three parts: a feature extractor, an aggregator, and a classification head. A two-stage training strategy was adopted for model training. Finally, we evaluated the performance of the model on the LZUFH_CRC dataset and compared it with other methods. Results: The results showed that the proposed model achieved an overall accuracy (ACC) of 0.524 and area under the receiver operating characteristic curve (AUC) of 0.791 on the LZUFH_CRC dataset. Among them, the grouping names MSI and NRAS had better classification performance, with F1-scores of 0.724 and 0.514, respectively. Additionally, the study visualized the feature activation maps to show the regions of interest of the model for different input images, finding that the model paid more attention to the transitional areas between tumor and non-tumor regions and the mesenchymal areas of the tumor. Meanwhile, comparisons among different clinical characteristic groups showed that the model did not exhibit significant biases in terms of gender, age and tumor location. Conclusions: This study proposed a fine-grained classification method for CRC based on DL technology, which combines H&E-stained tissue section images with DL technologies such as CNN and ViT, providing new insights into the molecular diagnosis of CRC. Although the performance of the model needs further improvement, the results indicate that DL technology has potential in the molecular detection of CRC. In the future, the research team will continue to optimize the model to improve the ACC and efficiency of fine-grained classification in CRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.